Mabsolve
Licenses Fc-silencing technology to developers of therapeutic antibodies and Fc fusion proteins
Highlights
- New on EvolcAdded 2026-11-14
About Mabsolve
mAbsolve develops STR, a set of Fc mutations designed to eliminate antibody effector function. It offers non-exclusive research and commercial licenses, with success-based milestone payments and no royalties.
The company serves developers of therapeutic antibodies and Fc fusion proteins. It is not developing its own biological therapeutics.
Mabsolve Limited was founded in 2019 and is headquartered in Oxford, United Kingdom.
Product: STR Fc-silencing technology licensed for research and commercial use.
Jobs at Mabsolve
Leadership
- Geoff Hale · Chief Executive OfficerSource: company website
More biotech & pharma companies
Macomics
Macrophage-directed drugs that clear large disease protein complexes, first targeting IgA nephropathy patientsMagnitude Biosciences
Contract research on C. elegans models and automated imaging for drug discovery, nutraceutical and consumer-goods R&DNew on EvolcMahashiv
Pharmaceutical development and manufacturing services for pharmaceutical companiesNew on EvolcManteisbio
Scientific and drug-development consulting for biotech, pharma, virtual companies, investors and public organizationsYoung companyNew on EvolcManx Healthcare
UK pharmaceutical manufacturer and distributor supplying generic and over-the-counter medicines to healthcare customersMariposa Therapeutics
Develops topical therapies for people with Epidermolysis Bullosa Simplex and other keratin-related conditionsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Contact Form 7High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
